Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +122.0% | +81.2% | 2 / 3 | -27.0% | -2.75 pp | +0.58 pp | +7.6% | 0.76 | 20.93 | 140 | −27,0% | 1,2 | +122,0% | 20.93 | 41.17 | −49,2% |
| Pts | 12 | 12 | 8 | 0 | 4 | 8 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 24.600 (close price on 2026-10-19)EPS (TTM): 1.175
Financial charts
1.Revenue & growth
VND bn140Q2/26
1.Revenue & growth
VND bn140Q2/26
2.Profit & growth
VND bn1,25Q2/26
3.Profit mix (Penman)
VND bn19,4Q2/26
4.Margins & cost structure
%10.0%Q2/26
5.Returns & cash cycle
% · days6.9%Q2/26
6.Earnings quality & cash
VND bn
7.Asset structure
VND bn373Q2/26
8.Funding & debt health
VND bn · times373Q2/26
9.Revenue backlog
VND bn3,22Q2/26
10.Valuation
times · %20,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %99Q2/26
Adjusted EPS growth, latest quarter
129%
Average adjusted EPS growth, 3 quarters
83.5%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26